Phoenix Holdings Ltd. Bei Gene, Ltd. Transaction History

Phoenix Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$248.56 - $389.34 $202,327 - $316,922	-814 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$249.6 - $403.14 $203,174 - $328,155	814 New	814 $293,000
Q2 2021 Aug 10, 2021	SELL	$292.75 - $367.01 $203,754 - $255,438	-696 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$260.64 - $382.12 $181,405 - $265,955	696 New	696 $232,000

251

45.6M

322K

144K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.